The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw

Marx, 2005, Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis: a growing epidemic, J Oral Maxillofac Surg, 61, 1115, 10.1016/S0278-2391(03)00720-1

Keck, 2003, Knochenstoffwechsel bei malignen Erkrankungen, Journal für Mineralstoffwechsel, 10, 6

Schmid, 2005, Pharmakologie der Bisphosphonate, 78

Marx, 2007

Ruggiero, 2006, Bisphosphonate-related osteonecrosis of the jaw, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, 433, 10.1016/j.tripleo.2006.06.004

2007, Position paper on bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 65, 369, 10.1016/j.joms.2006.11.003

Al-Nawas

Montebugnoli, 2007, Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, 473, 10.1016/j.tripleo.2007.01.008

Khan, 2008, Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw, J Rheumatol, 35, 1391

Khan, 2009, Bisphosphonate associated osteonecrosis of the jaw, J Rheumatol, 36, 478, 10.3899/jrheum.080759

Wutzl, 2008, Treatment results of bisphosphonate-related osteonecrosis of the jaws, Head Neck, 30, 1224, 10.1002/hed.20864

Abu-Id, 2008, “Bis-phossy jaws”—high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw, J Craniomaxillofac Surg, 36, 95, 10.1016/j.jcms.2007.06.008

Pautke, 2009, Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws, J Oral Maxillofac Surg, 67, 471, 10.1016/j.joms.2008.09.037

Carlson, 2009, The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 67, 85, 10.1016/j.joms.2009.01.006

Stockmann, 2010, Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up, Support Care Cancer, 18, 449, 10.1007/s00520-009-0688-1

Bianchi, 2007, Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, 249, 10.1016/j.tripleo.2007.01.040

Chiandussi, 2006, Clinical and diagnostic imaging of bisphosphonte-associated osteonecrosis of the jaws, Dentomaxillofac Radiol, 35, 236, 10.1259/dmfr/27458726

Wilde, 2009, Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107, 412, 10.1016/j.tripleo.2008.09.019

Fullmer, 2007, Cone beam computed tomographic findings in refractory chronic suppurative osteomyelitis of the mandible, Br J Oral Maxillofac Surg, 745, 364, 10.1016/j.bjoms.2006.10.009

Wilde, 2008, 3 D Volumentomographie in der Diagnostik und Operationsplanung bei Bisphosphonat assoziierten Kieferknochennekrosen, Journal der Deutschen Gesellschaft für Plastische und Wiederherstellungschirurgie, 20, 28

Kottal, 2009, Evaluation of radiographic findings in conebeam computed tomography volumes of patients with bisphosphonate induced osteonecrosis of the jaws, Int J CARS, 4, 216

Schulze, 2009, Radiation exposure during midfacial imaging using 4- and 16-slice computed tomography, cone beam computed tomography systems and conventional radiography, Dentomaxillofac Radiol, 33, 83, 10.1259/dmfr/28403350

Coppenrath, 2008, Schnittbildverfahren zur dentomaxillofazialen Diagnostik: Dosisvergleich von Dental-MSCT und NewTom® 9000 DVT, Fortschr Röntgenstr, 180, 396, 10.1055/s-2008-1027142

Hansen, 2006, Osteonecrosis of the jaws in patients treated with bisphosphonates—histomorphic analysis in comparison with infected osteoradionecrosis, J Oral Pathol Med, 35, 155, 10.1111/j.1600-0714.2006.00391.x

Bedogni, 2008, Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105, 358, 10.1016/j.tripleo.2007.08.040

Piesold, 2006, Osteonekrose der Kiefer unter Bisphosphonat-Langzeittherapie, Mund Kiefer Gesichtschir, 10, 287, 10.1007/s10006-006-0017-5

Magopoulos, 2007, Osteonecrosis of the jaws due to bisphosphonate use, Am J Otolaryngol, 28, 158, 10.1016/j.amjoto.2006.08.004

Conte, 2004, Safety of intravenous and oral bisphosphonates and compliance with dosing regimens, Oncologist, 9, 28, 10.1634/theoncologist.9-90004-28

Ross, 2004, A systematic review of the role of bisphosphonates in metastatic disease, Health Technol Assess, 8, 1, 10.3310/hta8040

Coleman, 2008, Risks and benefits of bisphosphonates, Br J Cancer, 98, 1736, 10.1038/sj.bjc.6604382

Cartsos, 2008, Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people, J Am Dent Assoc, 139, 23, 10.14219/jada.archive.2008.0016

Rateitschak, 1989, Parodontologie, Farbatlanten der Zahnmedizin 1, 158

Forth, 1996, Allgemeine und spezielle Pharmakologie und Toxikologie, 613